Related references
Note: Only part of the references are listed.Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
C. Sessa et al.
ANNALS OF ONCOLOGY (2023)
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
Taru Muranen et al.
NPJ BREAST CANCER (2023)
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy
Vincent M. T. de Jong et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
Isabelle Grootes et al.
EUROPEAN JOURNAL OF CANCER (2022)
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
H. J. Burstein et al.
ANNALS OF ONCOLOGY (2021)
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017
Daniel J. van Der Meer et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients
Karen Zaguirre et al.
CANCER MEDICINE (2021)
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer
Rim S. Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype
Iris Kramer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 30, pg 128, 2019)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
J. H. Park et al.
ANNALS OF ONCOLOGY (2019)
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
External validation of the PREDICT tool in Spanish women with breast cancer participating in population-based screening programmes
Urko Aguirre et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2019)
Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath
Solon Karapanagiotis et al.
CLINICAL CANCER RESEARCH (2018)
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study
Ellen R. Copson et al.
LANCET ONCOLOGY (2018)
Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data
Ewan Gray et al.
BRITISH JOURNAL OF CANCER (2018)
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years
Ellen G. Engelhardt et al.
EUROPEAN JOURNAL OF CANCER (2017)
Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population
M. C. van Maaren et al.
EUROPEAN JOURNAL OF CANCER (2017)
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study
Gwen M. H. E. Dackus et al.
BMJ OPEN (2017)
An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation
Francisco J. Candido dos Reis et al.
BREAST CANCER RESEARCH (2017)
Validity of the online PREDICT tool in older patients with breast cancer: a population-based study
N. A. de Glas et al.
BRITISH JOURNAL OF CANCER (2016)
An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ≤40 years at breast cancer diagnosis
T. Maishman et al.
BRITISH JOURNAL OF CANCER (2015)
The Predictive Accuracy of PREDICT: A Personalized Decision-Making Tool for Southeast Asian Women With Breast Cancer
Hoong-Seam Wong et al.
MEDICINE (2015)
Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer
Gordon C. Wishart et al.
BMC CANCER (2014)
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
G. C. Wishart et al.
BRITISH JOURNAL OF CANCER (2012)
Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancer
Yun Wu et al.
CANCER (2012)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
K. Albain et al.
LANCET (2012)
A population-based validation of the prognostic model PREDICT for early breast cancer
G. C. Wishart et al.
EJSO (2011)
Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer
Armando E. Giuliano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database
Philippe Autier et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer
Gordon C. Wishart et al.
BREAST CANCER RESEARCH (2010)
The Impact of Primary Tumor Size, Lymph Node Status, and Other Prognostic Factors on the Risk of Cancer Death
L. Leon Chen et al.
CANCER (2009)
Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer
Maaike de Boer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers
Andrew J. Vickers et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2008)
Occult axillary node metastases in breast cancer are prognostically significant: Results in 368 node-negative patients with 20-year follow-up
Lee K. Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the women's environment, cancer and radiation epidemiology study
Lisbeth Bertelsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands
Michael Schaapveld et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
Marc Buyse et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Evaluation of The Netherlands breast cancer screening programme
ALM Verbeek et al.
ANNALS OF ONCOLOGY (2003)
Share Paper
